Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: two cases report and review of the literature

Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study

(2018) Yanfang Hou et al.   BONE

Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn’s disease

(2018) Junji Umeno et al.   JOURNAL OF GASTROENTEROLOGY

Pachydermoperiostosis of the complete type: A novel missense mutation c.101T > C in the SLCO2A1 gene

(2017) Wenbin Ma et al.   European Journal of Medical Genetics

Primary Hypertrophic Osteoarthropathy With SLCO2A1 Mutation in a Chinese Patient Successfully Treated With Etoricoxib

(2017) Fangfang Sun et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention

(2017) Shan-Shan Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Successful treatment of pachydermoperiostosis patients with etoricoxib, aescin, and arthroscopic synovectomy

(2017) Hengyan Zhang et al.   MEDICINE

Identification of two novel mutations in the SLCO2A1 prostaglandin transporter gene in a Chinese patient with primary hypertrophic osteoarthropathy

(2017) Ting Guo et al.   Molecular Medicine Reports

Successful treatment of pachydermoperiostosis with etoricoxib in a patient with a homozygous splice-site mutation in the SLCO2A1 gene

(2016) Z.-T. Li et al.   BRITISH JOURNAL OF DERMATOLOGY

Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications

(2016) Sam Harirforoosh et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

A Common Mutation and a Novel Mutation in the HPGD Gene in Nine Patients with Primary Hypertrophic Osteoarthropathy

(2015) Lu Yuan et al.   CALCIFIED TISSUE INTERNATIONAL

Primary Hypertrophic Osteoarthropathy: An Update on Patient Features and Treatment

(2015) G. GIANCANE et al.   JOURNAL OF RHEUMATOLOGY

A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter

(2015) Junji Umeno et al.   PLoS Genetics

The complete type of pachydermoperiostosis: A novel nonsense mutation p.E141* of the SLCO2A1 gene

(2014) H. Niizeki et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Mutations in theSLCO2A1Gene and Primary Hypertrophic Osteoarthropathy: A Clinical and Biochemical Characterization

(2013) Zeng Zhang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Aberrant CD200/CD200R1 expression contributes to painful synovium hyperplasia in a patient with primary hypertrophic osteoarthropathy

(2013) Yan Ren et al.   RHEUMATOLOGY INTERNATIONAL

Cryptogenic multifocal ulcerating stenosing enteritis associated with homozygous deletion mutations in cytosolic phospholipase A2-α

(2012) Matthew A Brooke et al.   GUT

Exome Sequencing Identifies SLCO2A1 Mutations as a Cause of Primary Hypertrophic Osteoarthropathy

(2011) Zhenlin Zhang et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Prostaglandin EP Receptors Involved in Modulating Gastrointestinal Mucosal Integrity

(2010) Koji Takeuchi et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Cranio-osteoarthropathy: a rare variant of hypertrophic osteoarthropathy

(2009) X. Chen et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy

(2008) Sandeep Uppal et al.   NATURE GENETICS